FutureGen Biopharm Technology Co., Ltd. was founded in San Francisco, USA in 2014. The Chinese headquarters is now located in Beijing Daxing China.FutureGen Biopharm ("FutureGen"), an innovative biopharmaceutical company, to develop engineered immune cell therapies targeting Claudin 18.2 ("CLDN18.2") in solid tumors. The company has developed a Structure-based Targeted Evolution Platform ("STEP") and Cell-based Antibody Pannin...
FutureGen Biopharm Technology Co., Ltd. was founded in San Francisco, USA in 2014. The Chinese headquarters is now located in Beijing Daxing China.FutureGen Biopharm ("FutureGen"), an innovative biopharmaceutical company, to develop engineered immune cell therapies targeting Claudin 18.2 ("CLDN18.2") in solid tumors. The company has developed a Structure-based Targeted Evolution Platform ("STEP") and Cell-based Antibody Panning ("CAP") for antibody discovery and engineering with proprietary intellectual property rights, which can quickly and efficiently screen and optimize a series of candidate drugs
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.